Delivery Order 75N91019D00029-75N91020F00001
Award Date
9/1/20
Potential Completion Date
8/31/25
Potential Value
$2.7M
Federal Agency
National Cancer Institute
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued under the National Cancer Institute's (NCI) Genomic Characterization Center Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The prime contractor is The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a renowned biomedical and genomic research organization. The contract has a ceiling value of $3,890,489.86 and a period of performance through September 9, 2026. The contract supports the NCI Genomic Characterization Centers...
This federal contract award to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) provides DNA characterization services to support the genomic research initiatives of several National Cancer Institute (NCI) programs, including the Cancer Genome Characterization Center, Clinical Proteomic Tumor Analysis Consortium, and Division of Cancer Epidemiology and Genetics. The $19,570,872.26 firm-fixed-price delivery order was issued under the NCI Genomic Characterization...
This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...
This is a delivery order under a multi-year, multi-award Indefinite Delivery Contract (IDC) awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Broad Institute of MIT and Harvard. The $24,910,368.70 firm fixed-price task order is for the Broad Institute to provide genomics data generation, analysis, and management services in support of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) initiative. This work will...
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...
This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, for a Single Cell Sequencing Task Order under the NCI Genomic Characterization Centers master IDIQ contract. The period of performance is from September 16, 2019 to September 15, 2022, with a ceiling value of $190,664.68. The order is in support of NCI's Center for Cancer Genomics program and does not have a set-aside...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, to provide whole genome sequencing of sickle cell disease samples. The contract has a potential value of $187,500.00 and a completion date of July 6, 2023. The Broad Institute has extensive experience providing genomics and data services to the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $59,850 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute. The contract is for the delivery of 150 clinical whole genome sequencing services, with a completion date of September 30, 2024. Broad Clinical Laboratories is a specialized healthcare services provider that offers genetic testing and clinical genome sequencing to federal agencies, particularly the Department...
This is a $8,473,939.55 firm fixed-price delivery order awarded to The Broad Institute, Inc. by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The work is performed in support of the Centralized Omics Resource (CORE) program, which provides genomics data generation, analysis, and management services for the Trans-Omics for Precision Medicine (TOPMed) initiative. The Broad Institute is the prime contractor on this task order, which...